[Level of GM-CSF and IL-4 in serum of children with bronchial asthma]

Area of Science:

• Pediatric Allergy and Immunology
• Respiratory Medicine
• Immunology

Background:

• Bronchial asthma is a common chronic respiratory disease in children.
• Immune system dysregulation, involving cytokines like IL-4 and GM-CSF, is implicated in asthma pathogenesis.
• Understanding cytokine profiles can aid in diagnosing and managing pediatric asthma.

Purpose of the Study:

• To investigate serum concentrations of Immunoglobulin E (IgE), IL-4, and GM-CSF in children with bronchial asthma.
• To compare these levels with those in a control group of healthy children.
• To identify potential immunological markers associated with pediatric asthma.

Main Methods:

• Serum samples were collected from 35 children diagnosed with bronchial asthma (stages I and II) and 10 healthy children.
• Enzyme-Linked Immunosorbent Assay (ELISA) was used to quantify the concentrations of IgE, IL-4, and GM-CSF.
• Statistical analysis was performed to compare measurements between the asthma and control groups.

Main Results:

• Serum IL-4 concentration was significantly higher in children with asthma (0.06 ng/ml) compared to healthy controls (0.01 ng/ml).
• Serum GM-CSF concentration was lower in children with asthma (4.4 pg/ml) than in the control group (8.44 pg/ml).
• Serum IgE levels were also measured but not detailed in the provided abstract.

Conclusions:

• Elevated serum IL-4 and reduced serum GM-CSF may serve as indicators of bronchial asthma in children.
• These cytokine alterations suggest a role for specific immune pathways in the development of pediatric asthma.
• Further research is warranted to explore the diagnostic and therapeutic implications of these findings.